Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.34 |
| ▸ | TSPO | P30536 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19738266 | 0.99 | L3MBTL1 (0.49) | KDM4EL3MBTL1ATMKMT2AIL1R1 | |
| SCHEMBL16947142 | 0.99 | L3MBTL1 (0.49) | KDM4EL3MBTL1ATMKMT2AIL1R1 | |
| SCHEMBL17056416 | 0.99 | L3MBTL1 (0.49) | KDM4EL3MBTL1ATMKMT2AIL1R1 | |
| SCHEMBL17056419 | 0.99 | L3MBTL1 (0.49) | KDM4EL3MBTL1ATMKMT2AIL1R1 | |
| SCHEMBL16947126 | 0.99 | L3MBTL1 (0.49) | KDM4EL3MBTL1ATMKMT2AIL1R1 | |
| SCHEMBL23663682 | 0.99 | L3MBTL1 (0.49) | KDM4EL3MBTL1ATMKMT2AIL1R1 | |
| SCHEMBL19738316 | 0.99 | L3MBTL1 (0.49) | KDM4EL3MBTL1ATMKMT2AIL1R1 | |
| SCHEMBL17056422 | 0.99 | L3MBTL1 (0.51) | KDM4EL3MBTL1ATMKMT2AIL1R1 | |
| SCHEMBL17464010 | 0.97 | KDM4E (0.47) | KDM4EL3MBTL1ATMKMT2AIL1R1 | |
| SCHEMBL17250266 | 0.97 | L3MBTL1 (0.47) | KDM4EL3MBTL1ATMKMT2AIL1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11233202-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2022-01-25 | — | — | US | disclosed |
| US-20210226130-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2021-07-22 | — | — | US | disclosed |
| WO-2017217654-A1 | COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC APPARATUS THEREOF | 덕산네오룩스 주식회사 | 2017-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210226130-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | PIEZO1, OCIAD1, OR10J3 | KDM4E 1104/4885L3MBTL1 915/4885ATM 4045/4885 |
| US-11233202-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | PIEZO1, OCIAD1, OR10J3 | KDM4E 1104/4885L3MBTL1 915/4885ATM 4045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.